UW WELL-FIT Exercise Program for Cancer Patients
WELL-FIT
1 other identifier
interventional
200
1 country
1
Brief Summary
The purpose of this project is to help to manage the many cancer treatment side effects through cardiovascular and resistance exercise, and education with the goal of using program outcomes to contribute to current research.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable cancer
Started Jun 2014
Longer than P75 for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2014
CompletedFirst Submitted
Initial submission to the registry
February 9, 2016
CompletedFirst Posted
Study publicly available on registry
April 12, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
ExpectedMarch 30, 2025
March 1, 2025
11.8 years
February 9, 2016
March 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Maximal Exercise Test
Pre and post maximum workload using an electronic cycle ergometer in Watts
24 sessions (12 weeks)
Upper and Lower Limb Strength
pre and post strength in upper and lower limb muscles using a linear differential variable transducer (LVDT) measured in Newton.meters
24 sessions (12 weeks)
Body Mass Index
Pre and post body mass index (kg/m2)
24 sessions (12 weeks)
Percent Body Fat
Pre and Post percent body fat (units: %)
24 sessions (12 weeks)
Secondary Outcomes (2)
Glucose
24 sessions (12 weeks)
Lipids
24 sessions (12 weeks)
Study Arms (1)
Cardiovascular and strength training exercise
EXPERIMENTAL24 sessions (\~12 weeks) exercise
Interventions
Cardiovascular and resistance exercise training
Eligibility Criteria
You may qualify if:
- previously diagnosed with cancer and will currently be receiving some form of treatment (chemotherapy, radiation therapy or hormonal therapy)
You may not qualify if:
- Physical / health factors that prohibit exercise or lack of medical clearance from physician
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Waterloo
Waterloo, Ontario, N2L 3G1, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Caryl Russell, MSc
University of Waterloo
- PRINCIPAL INVESTIGATOR
Michael Sharratt, PhD
University of Waterloo
- PRINCIPAL INVESTIGATOR
Marina Mourtzakis, PhD
University of Waterloo
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research and Operations Manager
Study Record Dates
First Submitted
February 9, 2016
First Posted
April 12, 2016
Study Start
June 1, 2014
Primary Completion
March 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
March 30, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share